全球药物滥用治疗市场按类型、治疗类型、年龄层、治疗环境和地区划分

预计 2025 年全球药物滥用治疗市场规模为 118.2 亿美元，到 2032 年将达到 213.3 亿美元，2025 年至 2032 年的复合年增长率为 8.8%。

数字。 2025年全球市场占有率（按地区划分）

药物滥用治疗是指旨在控制药物依赖并帮助人们实现长期戒酒和康復的计划和活动。物质滥用障碍，也称为成瘾，是指强迫性或无法控制地使用有害和成瘾物质，儘管这些物质有负面影响。常见的滥用物质包括酒精、鸦片类药物、大麻、古柯碱和兴奋剂。物质滥用疾患的主要症状包括无法减少摄取量、产生渴望、不使用时出现戒断症状。成瘾者通常会经历自我控制能力下降、社交问题、危险使用，有时会产生身体依赖。药物滥用治疗旨在透过治疗性介入、咨商、药物治疗和社区支持计画来解决成瘾的生物、心理、社会和行为方面。全球范围内药物滥用率的上升刺激了对有效治疗方案的需求。

市场动态：

全球药物滥用治疗市场受到药物滥用障碍盛行率上升、对治疗有效性认识不断提高、有利的监管和报销政策以及新型药物辅助治疗产品的推出的推动。然而，与成瘾相关的社会耻辱、低收入地区缺乏治疗设施以及违规治疗通讯协定等问题可能会抑制市场成长。数位化治疗解决方案、综合护理模式、针对特定成瘾的针对性治疗以及向新兴市场的扩张为市场参与者带来了重大商机。从地区来看，北美凭藉先进的医疗保健基础设施和医疗意识占据市场主导地位。然而，预计亚太地区在预测期内将出现良好的成长。

本研究的主要特点

• 本报告对全球药物滥用治疗市场进行了详细分析，并提供了预测期（2025-2032）的市场规模和年复合成长率(CAGR)，假设 2024 年为基准年。
• 它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
• 它根据公司亮点、产品系列、关键亮点、财务业绩和策略等参数，对全球药物滥用治疗市场的主要企业进行了概述。
• 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
• 全球药物滥用治疗市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
• 相关人员将透过用于分析全球药物滥用治疗市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
• 药物和酒精消费量增加
• 政府和非政府组织的支持不断增加
  • 限制因素
• 与药物成瘾相关的社会耻辱
• 缺乏合适的復健设施
  • 机会
• 新兴国家尚未开发的市场
• 公司市场占有率分析
• 主要亮点
• 市场趋势
• PEST分析
• 波特分析
• 最近的产品核可/发布
• 合併、收购和合作

4. 全球药物滥用治疗市场-冠状病毒（COVID-19）大流行的影响

• COVID-19流行病学
• 供需侧分析
• 经济影响

5. 2020 年至 2032 年全球药物滥用治疗市场（按类型）

• 酒精
• 鸦片类药物（例如海洛因、处方止痛药）
• 烟草/尼古丁
• 古柯碱
• 大麻
• 甲基安非他命
• 其他非法药物（如苯二氮平类药物）

6. 2020 年至 2032 年按治疗类型分類的全球药物滥用治疗市场

• 阿片类药物
• 美沙酮
• Buprenornhine
• 缓释性纳曲酮
• 洛非西定
• 尼古丁
• 尼古丁替代疗法（可使用贴片、吸入器和口香糖）
• 安非他酮
• Varenicline
• 酒精
• 纳曲酮
• Disulfiram
• Acamprosate
• 烟草
• 可乐定
• 去甲替林
• 其他（托吡酯、Modafinil非尼等）

7. 2020 年至 2032 年按年龄族群分類的全球药物滥用治疗市场

• 青年
• 成人
• 老年人

8. 2020 年至 2032 年全球药物滥用治疗市场（依治疗环境划分）

• 门诊治疗
• 门诊
• 私人诊所
• 住院治疗
• 復健中心
• 医院
• 住宅治疗设施
• 戒毒中心

9. 2020 年至 2032 年全球药物滥用治疗市场（按地区）

• 北美洲
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东
• 非洲

第十章 竞争格局

• 公司简介
  • Indivior PLC
  • Pfizer, Inc.
  • Johnson &Johnson Inc.
  • Mallinckrodt Pharmaceuticals
  • Teva Pharmaceuticals, Inc.
  • Par Pharmaceutical, Inc.
  • USWM, LLC
  • Valeant Pharmaceuticals
  • Greenyard Pharmaceutical Ltd
  • Cipla Health Limited
  • Perrigo
  • Haleon Group of Companies
  • Ventus Medical
  • Glenmark
  • Other Prominent Players

第 11 章 章节

• 参考
• 调查方法
• 关于出版商

Global Substance Abuse Treatment Market is estimated to be valued at USD 11.82 Bn in 2025 and is expected to reach USD 21.33 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.

Figure. Global Substance Abuse Treatment Market Share (%), By Region 2025

Substance abuse treatment refers to programs and activities that are aimed at managing substance dependence and support long-term sobriety and recovery. Substance abuse disorder which is also known as addiction, involves the compulsive or uncontrollable use of harmful and addictive substances despite their negative impact. Common substances of abuse include alcohol, opioids, cannabis, cocaine, and methamphetamines. Some key signs of substance abuse disorder include the inability to reduce intake, experiencing cravings, and having withdrawal symptoms when not using. Those suffering from addiction often experience impaired control, social problems, risky use, and sometimes even physical dependence. Substance abuse treatment aims to address the biological, psychological, social, and behavioral aspects of addiction through therapeutic interventions, counseling, medication, and community support programs. The rise in substance abuse rates globally is fueling demand for effective treatment options.

Market Dynamics:

Global substance abuse treatment market is driven by the rising prevalence of substance abuse disorders, increasing awareness regarding treatment availability, favorable regulations and reimbursement policies, and the launch of novel medication-assisted treatment products. However, the market growth can be restrained by social stigmas that are associated with addiction, lack of access to treatment facilities in low-income regions, and non-compliance issues with treatment protocols. The development of digital therapeutic solutions, integrated care models, targeted therapies for specific addictions, and expansion to emerging markets present key opportunities for the market players. Geographically, North America dominates the market due to advanced healthcare infrastructure and awareness. However, the Asia Pacific region is expected to offer lucrative growth prospects during the forecast period.

Key Features of the Study:

• This report provides an in-depth analysis of the global substance abuse treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global substance abuse treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Indivior PLC, Pfizer, Inc., Johnson & Johnson Inc., Alkermes., Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Inc., Par Pharmaceutical, Inc., USWM, LLC, Valeant Pharmaceuticals, Greenyard Pharmaceutical Ltd. Cipla Health Limited. Perrigo, Haleon Group of Companies, Ventus Medical, Glenmark and other prominent players.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global substance abuse treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global substance abuse treatment market.

Detailed Segmentation:

• Global Substance Abuse Treatment Market, By Type
  • Alcohol
  • Opioids (e.g., heroin, prescription painkillers)
  • Tobacco/nicotine
  • Cocaine
  • Marijuana
  • Methamphetamines
  • Other illicit drugs (Benzodiazepines, etc.)
• Global Substance Abuse Treatment Market, By Treatment Type
  • Opioid
  • Methadone
  • Buprenorphine
  • Extended-release naltrexone
  • Lofexidine
  • Nicotine
  • Nicotine replacement therapies (available as a patch, inhaler, or gum)
  • Bupropion
  • Varenicline
  • Alcohol
  • Naltrexone
  • Disulfiram
  • Acamprosate
  • Tobacco
  • Clonidine
  • Nortriptyline
  • Others (Topiramate, Modafinil, etc.)
• Global Substance Abuse Treatment Market, By Age Group
  • Adolescents
  • Adults
  • Geriatric
• Global Substance Abuse Treatment Market, By Treatment Setting
  • Outpatient Treatment
  • Outpatient Clinics
  • Private Practices
  • Inpatient Treatment
  • Rehabilitation Centers
  • Hospitals
  • Residential Treatment Facilities
  • Detoxification Centers
• Global Substance Abuse Treatment Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles
  • Indivior PLC
  • Pfizer, Inc.
  • Johnson & Johnson Inc.
  • Mallinckrodt Pharmaceuticals
  • Teva Pharmaceuticals, Inc.
  • Par Pharmaceutical, Inc.
  • USWM, LLC
  • Valeant Pharmaceuticals
  • Greenyard Pharmaceutical Ltd
  • Cipla Health Limited
  • Perrigo
  • Haleon Group of Companies
  • Ventus Medical
  • Glenmark
  • Other Prominent Players

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Treatment Type
  • Market Snippet, By Age Group
  • Market Snippet, By Treatment Setting
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers:
• Increasing consumption of drugs and alcohol
• Growing support from government and NGOs
  • Restraints
• Social stigma associated with substance dependence
• Lack of adequate rehabilitation facilities
  • Opportunities
• Untapped markets in developing countries
• Company Market Share Analysis
• Key Highlights
• Market Trends
• PEST Analysis
• PORTER's Analysis
• Recent Product Approvals/Launches
• Mergers, Acquisitions, and Collaborations

4. Global Substance Abuse Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Substance Abuse Treatment Market, By Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Alcohol
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Opioids (e.g., heroin, prescription painkillers)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Tobacco/nicotine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Cocaine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Marijuana
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Methamphetamines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Other illicit drugs (Benzodiazepines, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Substance Abuse Treatment Market, By Treatment Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Opioid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Methadone
• Buprenorphine
• Extended-release naltrexone
• Lofexidine
• Nicotine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Nicotine replacement therapies (available as a patch, inhaler, or gum)
• Bupropion
• Varenicline
• Alcohol
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Naltrexone
• Disulfiram
• Acamprosate
• Tobacco
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Clonidine
• Nortriptyline
• Others (Topiramate, Modafinil, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Substance Abuse Treatment Market, By Age Group, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Adolescents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Adults
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Geriatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Substance Abuse Treatment Market, By Treatment Setting, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Outpatient Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Outpatient Clinics
• Private Practices
• Inpatient Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Rehabilitation Centers
• Hospitals
• Residential Treatment Facilities
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Detoxification Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global Substance Abuse Treatment Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profile
  • Indivior PLC
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Pfizer, Inc.
  • Johnson & Johnson Inc.
  • Mallinckrodt Pharmaceuticals
  • Teva Pharmaceuticals, Inc.
  • Par Pharmaceutical, Inc.
  • USWM, LLC
  • Valeant Pharmaceuticals
  • Greenyard Pharmaceutical Ltd
  • Cipla Health Limited
  • Perrigo
  • Haleon Group of Companies
  • Ventus Medical
  • Glenmark
  • Other Prominent Players
• Analyst Views

11. Section

• References
• Research Methodology
• About us